LEF1 and acute lymphoblastic leukemia: The main limitations of our study are that it was performed by using only one cell line, was not validated in T-ALL patients, and requires further functional investigations to confirm the implications of its results, including the potential role of DHRS2 in T-ALL and its interactions with LEF1.